Search research articles
Contact Us
Filters
Showing results (141-150 of 185) with videos related to
Page
of 19
Sort By:
Blood Science (Baltimore, Md.)
|
January 19, 2024
Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
Ying Yu, Wenjie Xiong, Tingyu Wang, et al.
Journal of Translational Medicine
|
December 9, 2022
Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia
Hao Sun, Teng Fang, Tingyu Wang, et al.
Frontiers in Immunology
|
July 24, 2023
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China
Yuting Yan, Rui Lv, Tingyu Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 11, 2022
Efficient delivery of Echinococcus multilocularis miRNAs using chitosan nanoparticles
Yue Sun, Yongjie Kou, Xuedong He, et al.
Haematologica
|
January 11, 2024
Rituximab plus cyclophosphamide and dexamethasone <i>versus</i> bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial
Wenjie Xiong, Rui Lyu, Ying Yu, et al.
Cancer Letters
|
August 22, 2013
Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer
Teng Ji, Danni Gong, Zhiqiang Han, et al.
British Journal of Haematology
|
July 30, 2021
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma
Rui Lyu, Tingyu Wang, Yi Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
Wenjie Xiong, Yuting Yan, Tingyu Wang, et al.
Cancer Research Communications
|
September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
Jiahui Liu, Wenqiang Yan, Huishou Fan, et al.
The Oncologist
|
June 28, 2025
Comparative analysis of patients' characteristics, treatment, and survival outcomes in CLL from China and the United States
Yuting Yan, Yin Liu, Tonglu Qiu, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 185) with videos related to
Sort By:
Page
of 19
Blood Science (Baltimore, Md.)
|
January 19, 2024
Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
Ying Yu, Wenjie Xiong, Tingyu Wang, et al.
Journal of Translational Medicine
|
December 9, 2022
Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia
Hao Sun, Teng Fang, Tingyu Wang, et al.
Frontiers in Immunology
|
July 24, 2023
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China
Yuting Yan, Rui Lv, Tingyu Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 11, 2022
Efficient delivery of Echinococcus multilocularis miRNAs using chitosan nanoparticles
Yue Sun, Yongjie Kou, Xuedong He, et al.
Haematologica
|
January 11, 2024
Rituximab plus cyclophosphamide and dexamethasone <i>versus</i> bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial
Wenjie Xiong, Rui Lyu, Ying Yu, et al.
Cancer Letters
|
August 22, 2013
Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer
Teng Ji, Danni Gong, Zhiqiang Han, et al.
British Journal of Haematology
|
July 30, 2021
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma
Rui Lyu, Tingyu Wang, Yi Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
Wenjie Xiong, Yuting Yan, Tingyu Wang, et al.
Cancer Research Communications
|
September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
Jiahui Liu, Wenqiang Yan, Huishou Fan, et al.
The Oncologist
|
June 28, 2025
Comparative analysis of patients' characteristics, treatment, and survival outcomes in CLL from China and the United States
Yuting Yan, Yin Liu, Tonglu Qiu, et al.
Page
of 19